The firm’s double-focused multi-leaf collimator (MLC) technology allows delivery of sharp radiation beams. The firm has developed radio frequency (RF) “cloaking” technology to prevent RF emitted by the Linac from destroying the MR image quality as well as magnetic shielding technology to enable undistorted delivery of radiation.
First MRI-guided system to fit in standard vaultsĬurrently, innovators at ViewRay have met the challenge of combining the proven cancer treatment capabilities of a Linac with the soft tissue imaging capabilities of MRI. First system to exclusively use Monte Carlo Treatment Planning System (TPS) First system to provide direct soft tissue tracking First and only CE-marked MRI-guided RT system First and only FDA-cleared MRI-guided RT system First patient treated with MRI-guided RT
VRAY 2016 TRACKER SERIES
ViewRay’s research efforts have established a series of industry firsts in product design such as: It allows clinicians to simultaneously image and treat patients suffering from cancer. VRAY’s MRIdian-Cobalt is the first and only MRI-guided radiation therapy system in the market. The MRIdian was developed by VRAY in collaboration with Siemens Healthcare, which integrates a Cobalt therapy unit with a low field MRI scanner. Within a year the firm was uplisted to the NASDAQ Global Market ( VRAY) in March 2016. ( VRAY) became a public company ( VRAY) via a reverse merger last year (July 2015). MRI, on the other hand, offers very fast volume acquisitions and can image biologic as well as physiologic activity. CBCT imaging systems currently in the market are relatively slow taking about one minute to acquire a volumetric image set.